122 related articles for article (PubMed ID: 38052321)
1. Targeting lipid biosynthesis on the basis of conventional treatments for clear cell renal cell carcinoma: A promising therapeutic approach.
Guo T; Zhang X; Chen S; Wang X; Wang X
Life Sci; 2024 Jan; 336():122329. PubMed ID: 38052321
[TBL] [Abstract][Full Text] [Related]
2. E2F1 promotes proliferation and metastasis of clear cell renal cell carcinoma via activation of SREBP1-dependent fatty acid biosynthesis.
Shen D; Gao Y; Huang Q; Xuan Y; Yao Y; Gu L; Huang Y; Zhang Y; Li P; Fan Y; Tang L; Du S; Wu S; Wang H; Wang C; Gong H; Pang Y; Ma X; Wang B; Zhang X
Cancer Lett; 2021 Aug; 514():48-62. PubMed ID: 34019961
[TBL] [Abstract][Full Text] [Related]
3. HIF2α-induced upregulation of RNASET2 promotes triglyceride synthesis and enhances cell migration in clear cell renal cell carcinoma.
Quan Y; Dai J; Zhou S; Zhao L; Jin L; Long Y; Liu S; Hu Y; Liu Y; Zhao J; Ding Z
FEBS Open Bio; 2023 Apr; 13(4):638-654. PubMed ID: 36728187
[TBL] [Abstract][Full Text] [Related]
4. GPX8 regulates clear cell renal cell carcinoma tumorigenesis through promoting lipogenesis by NNMT.
Nguyen TTM; Nguyen TH; Kim HS; Dao TTP; Moon Y; Seo M; Kang S; Mai VH; An YJ; Jung CR; Kim JM; Park S
J Exp Clin Cancer Res; 2023 Feb; 42(1):42. PubMed ID: 36750850
[TBL] [Abstract][Full Text] [Related]
5. ACSL3 regulates lipid droplet biogenesis and ferroptosis sensitivity in clear cell renal cell carcinoma.
Klasson TD; LaGory EL; Zhao H; Huynh SK; Papandreou I; Moon EJ; Giaccia AJ
Cancer Metab; 2022 Oct; 10(1):14. PubMed ID: 36192773
[TBL] [Abstract][Full Text] [Related]
6. The glutathione redox system is essential to prevent ferroptosis caused by impaired lipid metabolism in clear cell renal cell carcinoma.
Miess H; Dankworth B; Gouw AM; Rosenfeldt M; Schmitz W; Jiang M; Saunders B; Howell M; Downward J; Felsher DW; Peck B; Schulze A
Oncogene; 2018 Oct; 37(40):5435-5450. PubMed ID: 29872221
[TBL] [Abstract][Full Text] [Related]
7. WY-14643 attenuates lipid deposition via activation of the PPARα/CPT1A axis by targeting Gly335 to inhibit cell proliferation and migration in ccRCC.
Wang R; Zhao J; Jin J; Tian Y; Lan L; Wang X; Zhu L; Wang J
Lipids Health Dis; 2022 Nov; 21(1):121. PubMed ID: 36384580
[TBL] [Abstract][Full Text] [Related]
8. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
Rabjerg M
Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
[TBL] [Abstract][Full Text] [Related]
9. Deficiency of the X-inactivation escaping gene
Zheng Q; Li P; Zhou X; Qiang Y; Fan J; Lin Y; Chen Y; Guo J; Wang F; Xue H; Xiong J; Li F
Theranostics; 2021; 11(18):8674-8691. PubMed ID: 34522206
[No Abstract] [Full Text] [Related]
10. Metabolic and Lipidomic Reprogramming in Renal Cell Carcinoma Subtypes Reflects Regions of Tumor Origin.
Schaeffeler E; Büttner F; Reustle A; Klumpp V; Winter S; Rausch S; Fisel P; Hennenlotter J; Kruck S; Stenzl A; Wahrheit J; Sonntag D; Scharpf M; Fend F; Agaimy A; Hartmann A; Bedke J; Schwab M
Eur Urol Focus; 2019 Jul; 5(4):608-618. PubMed ID: 29452772
[TBL] [Abstract][Full Text] [Related]
11. Targeting the transcription factor receptor LXR to treat clear cell renal cell carcinoma: agonist or inverse agonist?
Wu G; Wang Q; Xu Y; Li J; Zhang H; Qi G; Xia Q
Cell Death Dis; 2019 May; 10(6):416. PubMed ID: 31138790
[TBL] [Abstract][Full Text] [Related]
12. Features of increased malignancy in eosinophilic clear cell renal cell carcinoma.
Nilsson H; Lindgren D; Axelson H; Brueffer C; Saal LH; Lundgren J; Johansson ME
J Pathol; 2020 Dec; 252(4):384-397. PubMed ID: 32815150
[TBL] [Abstract][Full Text] [Related]
13. HO-1 Contributes to Luteolin-Triggered Ferroptosis in Clear Cell Renal Cell Carcinoma via Increasing the Labile Iron Pool and Promoting Lipid Peroxidation.
Han S; Lin F; Qi Y; Liu C; Zhou L; Xia Y; Chen K; Xing J; Liu Z; Yu W; Zhang Y; Zhou X; Rao T; Cheng F
Oxid Med Cell Longev; 2022; 2022():3846217. PubMed ID: 35656025
[TBL] [Abstract][Full Text] [Related]
14. Obesity-Dependent Adipokine Chemerin Suppresses Fatty Acid Oxidation to Confer Ferroptosis Resistance.
Tan SK; Mahmud I; Fontanesi F; Puchowicz M; Neumann CKA; Griswold AJ; Patel R; Dispagna M; Ahmed HH; Gonzalgo ML; Brown JM; Garrett TJ; Welford SM
Cancer Discov; 2021 Aug; 11(8):2072-2093. PubMed ID: 33757970
[TBL] [Abstract][Full Text] [Related]
15. HAO2 inhibits malignancy of clear cell renal cell carcinoma by promoting lipid catabolic process.
Xiao W; Wang X; Wang T; Chen B; Xing J
J Cell Physiol; 2019 Dec; 234(12):23005-23016. PubMed ID: 31127626
[TBL] [Abstract][Full Text] [Related]
16. Overexpression CPT1A reduces lipid accumulation via PPARα/CD36 axis to suppress the cell proliferation in ccRCC.
Yang H; Zhao H; Ren Z; Yi X; Zhang Q; Yang Z; Kuang Y; Zhu Y
Acta Biochim Biophys Sin (Shanghai); 2022 Jan; 54(2):220-231. PubMed ID: 35130611
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-4735-3p Facilitates Ferroptosis in Clear Cell Renal Cell Carcinoma by Targeting SLC40A1.
Zhu C; Song Z; Chen Z; Lin T; Lin H; Xu Z; Ai F; Zheng S
Anal Cell Pathol (Amst); 2022; 2022():4213401. PubMed ID: 35646516
[TBL] [Abstract][Full Text] [Related]
18. Fast clearance of lipid droplets through MAP1S-activated autophagy suppresses clear cell renal cell carcinomas and promotes patient survival.
Xu G; Jiang Y; Xiao Y; Liu XD; Yue F; Li W; Li X; He Y; Jiang X; Huang H; Chen Q; Jonasch E; Liu L
Oncotarget; 2016 Feb; 7(5):6255-65. PubMed ID: 26701856
[TBL] [Abstract][Full Text] [Related]
19. AUP1 regulates lipid metabolism and induces lipid accumulation to accelerate the progression of renal clear cell carcinoma.
Chen C; Zhao W; Lu X; Ma Y; Zhang P; Wang Z; Cui Z; Xia Q
Cancer Sci; 2022 Aug; 113(8):2600-2615. PubMed ID: 35633317
[TBL] [Abstract][Full Text] [Related]
20. HIF2α-Dependent Lipid Storage Promotes Endoplasmic Reticulum Homeostasis in Clear-Cell Renal Cell Carcinoma.
Qiu B; Ackerman D; Sanchez DJ; Li B; Ochocki JD; Grazioli A; Bobrovnikova-Marjon E; Diehl JA; Keith B; Simon MC
Cancer Discov; 2015 Jun; 5(6):652-67. PubMed ID: 25829424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
